UK investigates weight-loss jab risks after many hospitalised with pancreatitis
The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in developing acute pancreatitis after taking GLP-1 weight-loss drugs like Ozempic, Mounjaro, and Wegovy.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
